Exponent Inc
NASDAQ:EXPO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
74.81
115.28
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Exponent Inc
Exponent Inc
Cost of Revenue
Exponent Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Exponent Inc
NASDAQ:EXPO
|
Cost of Revenue
-$36.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
TransUnion
NYSE:TRU
|
Cost of Revenue
-$1.7B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-13%
|
|
|
Equifax Inc
NYSE:EFX
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-12%
|
|
|
Leidos Holdings Inc
NYSE:LDOS
|
Cost of Revenue
-$13.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-12%
|
|
|
Verisk Analytics Inc
NASDAQ:VRSK
|
Cost of Revenue
-$896.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
|
CoStar Group Inc
NASDAQ:CSGP
|
Cost of Revenue
-$553.9m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-14%
|
|
Exponent Inc
Glance View
Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of engineering, scientific, environmental, and health consulting services. The company is headquartered in Menlo Park, California and currently employs 1,215 full-time employees. The firm's service offerings are provided on a project-by-project basis. Its segments include Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment is a service group providing technical consulting in different practices primarily in engineering, including biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences and vehicle engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis, including chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences, and health sciences.
See Also
What is Exponent Inc's Cost of Revenue?
Cost of Revenue
-36.1m
USD
Based on the financial report for Sep 29, 2024, Exponent Inc's Cost of Revenue amounts to -36.1m USD.
What is Exponent Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%
Over the last year, the Cost of Revenue growth was 21%. The average annual Cost of Revenue growth rates for Exponent Inc have been -9% over the past three years , -8% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
